Healthcare companies by risk reading
Healthcare companies by risk reading: 1,214 companies ranked by a composite risk reading built from filed statements -- leverage, cash conversion, operating pressure, customer and supplier concentration and competitive position. Recomputed 1 September 2026.
Composite readings for 8,308 companies, recomputed 1 September 2026. A company appears here once at least three weighted categories cleared their inputs; the rest carry per-mechanism readings without a headline.
| Company | Reading | Band | Sector | Country | Coverage | Market cap |
|---|---|---|---|---|---|---|
| Marker Therapeutics Inc MRKR | 59 | Elevated | Healthcare | United States | 3 / 6 | $22M |
| ABVC BioPharma Inc ABVC | 98 | Acute | Healthcare | United States | 3 / 6 | $22M |
| Longeveron Inc - Class A LGVN | 67 | Stretched | Healthcare | United States | 5 / 6 | $22M |
| FARMACOSMO COSMO.MI | 58 | Elevated | Healthcare | Italy | 5 / 6 | $22M |
| Retractable Technologies Inc RVP | 56 | Elevated | Healthcare | United States | 5 / 6 | $22M |
| Provexis plc NZCA | 22 | Normal | Healthcare | United Kingdom | 3 / 6 | $22M |
| Biofrontera Inc BFRI | 34 | Normal | Healthcare | United States | 5 / 6 | $22M |
| Rewalk Robotics Ltd LFWD | 56 | Elevated | Healthcare | Israel | 5 / 6 | $22M |
| Cytosorbents Corp CTSO | 62 | Stretched | Healthcare | United States | 4 / 6 | $21M |
| Allurion Technologies Inc ALUR | 67 | Stretched | Healthcare | United States | 4 / 6 | $21M |
| I.M.D. International Medical Devices S.p.A. X74 | 38 | Normal | Healthcare | Italy | 5 / 6 | $20M |
| Dyadic International Inc DE DYAI | 74 | Stretched | Healthcare | United States | 4 / 6 | $20M |
| Concord Medical Services CCM | 53 | Elevated | Healthcare | China | 5 / 6 | $20M |
| EZZ Life Science Holdings Ltd EZZ | 17 | Contained | Healthcare | Australia | 4 / 6 | $20M |
| Cosmos Health Inc COSM | 59 | Elevated | Healthcare | Greece | 4 / 6 | $20M |
| MAINZ BIOMED B.V. EO 1 4TO | 66 | Stretched | Healthcare | Germany | 5 / 6 | $19M |
| Proteomics International Laboratories Ltd PIQ | 73 | Stretched | Healthcare | Australia | 4 / 6 | $19M |
| Biosynex ALBIO | 68 | Stretched | Healthcare | France | 5 / 6 | $19M |
| IM Cannabis Corp IMCC | 39 | Normal | Healthcare | Canada | 5 / 6 | $19M |
| CelLBxHealth plc CLBX | 62 | Stretched | Healthcare | United Kingdom | 5 / 6 | $19M |
| Lexaria Bioscience Corp LEXX | 47 | Elevated | Healthcare | Canada | 5 / 6 | $19M |
| Lipocine Inc LPCN | 49 | Elevated | Healthcare | United States | 3 / 6 | $18M |
| Virax Biolabs Group Ltd - Class A VRAX | 46 | Elevated | Healthcare | United Kingdom | 5 / 6 | $18M |
| ANGLE plc DWV | 63 | Stretched | Healthcare | United Kingdom | 5 / 6 | $18M |
| Jin Medical International Ltd ZJYL | 59 | Elevated | Healthcare | China | 5 / 6 | $18M |
| Trajan Group Holdings Ltd TRJ | 32 | Normal | Healthcare | Australia | 4 / 6 | $18M |
| Picard Medical Inc PMI | 57 | Elevated | Healthcare | United States | 4 / 6 | $17M |
| PROBIOTIX HEALTH LS-05 X90 | 42 | Elevated | Healthcare | United Kingdom | 4 / 6 | $17M |
| 111 Inc YI | 46 | Elevated | Healthcare | China | 5 / 6 | $17M |
| OTOFARMA OTO.MI | 25 | Normal | Healthcare | Italy | 4 / 6 | $17M |
| Pulsenmore Ltd PLSM | 32 | Normal | Healthcare | Israel | 5 / 6 | $17M |
| Poxel SA POXEL | 42 | Elevated | Healthcare | France | 3 / 6 | $17M |
| EUROPEAN MEDICAL SOLUTIONS ALEMS | 26 | Normal | Healthcare | Belgium | 5 / 6 | $17M |
| Euromedis Groupe SA ALEMG | 34 | Normal | Healthcare | France | 4 / 6 | $16M |
| Neurotech International Ltd NTI | 79 | Stretched | Healthcare | Australia | 3 / 6 | $16M |
| Scienture Holdings Inc SCNX | 71 | Stretched | Healthcare | United States | 3 / 6 | $16M |
| Pluri Inc PLUR | 52 | Elevated | Healthcare | Israel | 5 / 6 | $16M |
| Cyclerion Therapeutics Inc CYCN | 60 | Stretched | Healthcare | United States | 3 / 6 | $16M |
| Thalia Therapeutics Plc THAT | 60 | Stretched | Healthcare | United Kingdom | 3 / 6 | $16M |
| Aptamer Group PLC APTA | 74 | Stretched | Healthcare | United Kingdom | 5 / 6 | $15M |
| Radiopharm Theranostics Ltd RAD | 36 | Normal | Healthcare | Australia | 3 / 6 | $15M |
| Nanologica AB NICA | 44 | Elevated | Healthcare | Sweden | 3 / 6 | $15M |
| ReShape Lifesciences Inc HIND | 73 | Stretched | Healthcare | United States | 3 / 6 | $15M |
| NeuroOne Medical Technologies Corp NMTC | 33 | Normal | Healthcare | United States | 5 / 6 | $15M |
| Celyad SA CYAD | 64 | Stretched | Healthcare | Belgium | 5 / 6 | $14M |
| Bionano Genomics Inc BNGO | 57 | Elevated | Healthcare | United States | 3 / 6 | $14M |
| Observe Medical Asa OBSRV | 55 | Elevated | Healthcare | Norway | 5 / 6 | $14M |
| EUKEDOS EUK.MI | 44 | Elevated | Healthcare | Italy | 5 / 6 | $14M |
| Lisata Therapeutics Inc LSTA | 62 | Stretched | Healthcare | United States | 4 / 6 | $14M |
| SeaStar Medical Holding Corp ICU | 48 | Elevated | Healthcare | United States | 4 / 6 | $13M |
| Intelicare Holdings Ltd ICR | 49 | Elevated | Healthcare | Australia | 4 / 6 | $13M |
| Boule Diagnostics AB BOUL | 51 | Elevated | Healthcare | Sweden | 4 / 6 | $13M |
| Syra Health Corp - Class A SYRA | 46 | Elevated | Healthcare | United States | 4 / 6 | $13M |
| Observe Medical ASA OM50 | 55 | Elevated | Healthcare | Norway | 5 / 6 | $13M |
| VIDAVO S.A. VIDAVO | 23 | Normal | Healthcare | Greece | 5 / 6 | $13M |
| IRIDEX Corp IRIX | 48 | Elevated | Healthcare | United States | 4 / 6 | $13M |
| Scandinavian Medical Solutions AS SMSMED | 42 | Elevated | Healthcare | Denmark | 5 / 6 | $12M |
| CRISM Therapeutics Corporation CRTX | 56 | Elevated | Healthcare | British Virgin Islands | 4 / 6 | $12M |
| Bioline Rx Ltd BLRX | 76 | Stretched | Healthcare | Israel | 5 / 6 | $12M |
| Caring Brands Inc CABR | 81 | Acute | Healthcare | United States | 3 / 6 | $12M |
| Imexhs Ltd IME | 28 | Normal | Healthcare | Australia | 4 / 6 | $12M |
| Vitura Health Ltd VIT | 25 | Normal | Healthcare | Australia | 4 / 6 | $12M |
| Senti Biosciences Inc SNTI | 84 | Acute | Healthcare | United States | 4 / 6 | $12M |
| Aspire Biopharma Holdings Inc ASBP | 78 | Stretched | Healthcare | United States | 3 / 6 | $12M |
| Dare Bioscience Inc DARE | 62 | Stretched | Healthcare | United States | 5 / 6 | $12M |
| VistaGen Therapeutics Inc VTGN | 49 | Elevated | Healthcare | United States | 5 / 6 | $12M |
| CytoMed Therapeutics Ltd GDTC | 54 | Elevated | Healthcare | Singapore | 5 / 6 | $11M |
| Femasys Inc FEMY | 41 | Elevated | Healthcare | United States | 5 / 6 | $10M |
| AMA Corp PLC ALAMA | 86 | Acute | Healthcare | France | 5 / 6 | $10M |
| OPTHEA LTD UKJ | 76 | Stretched | Healthcare | Australia | 4 / 6 | $10M |
| SINTX Technologies Inc SINT | 75 | Stretched | Healthcare | United States | 4 / 6 | $10M |
| Heart Test Laboratories Inc HSCS | 74 | Stretched | Healthcare | United States | 5 / 6 | $10M |
| Spineguard ALSGD | 56 | Elevated | Healthcare | France | 5 / 6 | $10M |
| MARINOMED BIOTECH AG INH. 93Z | 38 | Normal | Healthcare | Austria | 5 / 6 | $10M |
| Xenetic Biosciences Inc XBIO | 14 | Contained | Healthcare | United States | 3 / 6 | $10M |
| Bellevue Life Sciences Acquisition Corp OSRH | 91 | Acute | Healthcare | United States | 5 / 6 | $10M |
| American Shared Hospital Services AMS | 45 | Elevated | Healthcare | United States | 4 / 6 | $10M |
| Traws Pharma Inc TRAW | 60 | Stretched | Healthcare | United States | 3 / 6 | $9M |
| Scinai Immunotherapeutics Ltd SCNI | 60 | Stretched | Healthcare | Israel | 5 / 6 | $9M |
| PREDICT PRE.MI | 31 | Normal | Healthcare | Italy | 5 / 6 | $8M |
| Epsilon Healthcare Ltd EPN | 29 | Normal | Healthcare | Australia | 4 / 6 | $8M |
| Glycorex Transplantation AB (publ) O33 | 32 | Normal | Healthcare | Sweden | 4 / 6 | $8M |
| OptiBiotix Health Plc OPTI | 55 | Elevated | Healthcare | United Kingdom | 3 / 6 | $8M |
| Hong Kong Pharma Digital Technology Holdings Ltd HKPD | 54 | Elevated | Healthcare | Hong Kong | 4 / 6 | $8M |
| CodeLab Capital AS P990 | 52 | Elevated | Healthcare | Norway | 4 / 6 | $8M |
| Cuprina Holdings (Cayman) Ltd - Class A CUPR | 75 | Stretched | Healthcare | Singapore | 5 / 6 | $8M |
| XWELL Inc XWEL | 66 | Stretched | Healthcare | United States | 4 / 6 | $8M |
| Bolt Biotherapeutics Inc BOLT | 52 | Elevated | Healthcare | United States | 5 / 6 | $8M |
| Wellgistics Health Inc WGRX | 94 | Acute | Healthcare | United States | 4 / 6 | $8M |
| OPTIBIOTIX HLTH PLC LS-02 OB3 | 56 | Elevated | Healthcare | United Kingdom | 3 / 6 | $8M |
| Evogene Ltd EVGN | 50 | Elevated | Healthcare | Israel | 5 / 6 | $7M |
| Nutex Investments PLC NUTEX | 73 | Stretched | Healthcare | Hungary | 4 / 6 | $7M |
| Mangoceuticals Inc MGRX | 58 | Elevated | Healthcare | United States | 3 / 6 | $7M |
| Oxford Biodynamics PLC OBD | 61 | Stretched | Healthcare | United Kingdom | 5 / 6 | $7M |
| Verici Dx Plc VRCI | 59 | Elevated | Healthcare | United Kingdom | 4 / 6 | $7M |
| Pila Pharma AB PILA | 75 | Stretched | Healthcare | Sweden | 3 / 6 | $7M |
| Media Lab SpA MLLAB | 27 | Normal | Healthcare | Italy | 5 / 6 | $7M |
| ECS Botanics Holdings Ltd ECS | 16 | Contained | Healthcare | Australia | 4 / 6 | $7M |
| ONCODES.PREC.MED. EO-34 ZR8 | 41 | Elevated | Healthcare | France | 3 / 6 | $7M |
| Oncodesign Precision Medicine ALOPM | 41 | Elevated | Healthcare | France | 3 / 6 | $7M |
By sector
Industrials 1,536Technology 1,292Healthcare 1,214Consumer Cyclical 1,116Basic Materials 577Communication Services 565Real Estate 552Consumer Defensive 536Energy 356Utilities 232
How the reading is built
Each company is scored on six mechanisms -- market expectation, operating pressure, cash conversion, leverage, concentration and competitive position -- from its own filed statements. A mechanism whose inputs do not clear its coverage floor is left unread rather than scored zero, and a reading built on thin coverage is pulled toward a neutral prior rather than claiming safety from what nobody looked at.
Descriptive, not advisory. These bands describe measured mechanisms; they are not investment advice, not a forecast, and not a statement about whether a share is worth owning.